Drug treatment of hyperlipidaemia: a guide to the rational use of lipid-lowering drugs (Q37771014)

22 August 2017

1 reference

title

Drug treatment of hyperlipidaemia: a guide to the rational use of lipid-lowering drugs (English)

1 reference

22 August 2017

1 reference

Peter P Toth

1

1 reference

22 August 2017

1 July 2010

1 reference

22 August 2017

1 reference

22 August 2017

70

1 reference

22 August 2017

11

1 reference

22 August 2017

1363-1379

1 reference

https://scigraph.springernature.com/pub.10.2165/10898610-000000000-00000

22 August 2017

0 references

cites work

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations

1 reference

https://api.crossref.org/works/10.2165%2F10898610-000000000-00000

Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F10898610-000000000-00000

HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F10898610-000000000-00000

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F10898610-000000000-00000

Improved control of niacin-induced flushing using an optimized once-daily, extended-release niacin formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F10898610-000000000-00000

Mechanistic studies on metabolic interactions between gemfibrozil and statins

21 January 2018

1 reference

12 December 2020

Use of ezetimibe in the United States and Canada

1 reference

12 December 2020

Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency

1 reference

12 December 2020

Low-density lipoprotein reduction in high-risk patients: how low do you go?

1 reference

12 December 2020

Comparative effects of lipid-lowering therapies

1 reference

12 December 2020

Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia

1 reference

12 December 2020

Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with sta

1 reference

12 December 2020

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

12 December 2020

Inflammation in atherosclerosis: from pathophysiology to practice

1 reference

12 December 2020

Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia

1 reference

12 December 2020

Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications

1 reference

12 December 2020

Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization

1 reference

12 December 2020

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

12 December 2020

PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect

1 reference

12 December 2020

Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes

1 reference

12 December 2020

Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT).

1 reference

12 December 2020

Making a case for quantitative assessment of cardiovascular risk

1 reference

12 December 2020

Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione.

1 reference

12 December 2020

Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study

1 reference

12 December 2020

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

1 reference

12 December 2020

Safety and tolerability of prolonged-release nicotinic acid in statin-treated patients

1 reference

12 December 2020

Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption

1 reference

12 December 2020

Implications of recent statin trials for primary care practice

1 reference

12 December 2020

Studies of cardiovascular disease and cause-specific mortality trends in Japanese-American men living in Hawaii and risk factor comparisons with other Japanese populations in the Pacific region: a review

1 reference

12 December 2020

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

1 reference

12 December 2020

Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively

1 reference

12 December 2020

SPARCL: the glimmer of statins for stroke risk reduction

1 reference

12 December 2020

Epidemiology of triglycerides: a view from Framingham

1 reference

12 December 2020

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

12 December 2020

Subclinical atherosclerosis: what it is, what it means and what we can do about it.

1 reference

12 December 2020

Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins

1 reference

12 December 2020

When high is low: raising low levels of high-density lipoprotein cholesterol

1 reference

12 December 2020

Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy

1 reference

12 December 2020

Aspirin reduces cutaneous flushing after administration of an optimized extended-release niacin formulation

1 reference

12 December 2020

Perspectives in cholesterol-lowering therapy: the role of ezetimibe, a new selective inhibitor of intestinal cholesterol absorption

1 reference

12 December 2020

Triglycerides and the Risk of Coronary Heart Disease

1 reference

12 December 2020

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

12 December 2020

Nicotinic acid (niacin) receptor agonists: will they be useful therapeutic agents?

1 reference

12 December 2020

Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?

1 reference

12 December 2020

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis

1 reference

12 December 2020

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

12 December 2020

Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia

1 reference

12 December 2020

Regulation of carbohydrate metabolism by the farnesoid X receptor

1 reference

12 December 2020

Gender difference in the level of high-density lipoprotein cholesterol in elderly Japanese patients with coronary artery disease

1 reference

12 December 2020

Effects of combination lipid therapy in type 2 diabetes mellitus

1 reference

12 December 2020

Extended-release niacin or ezetimibe and carotid intima-media thickness.

1 reference

12 December 2020

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis

1 reference

12 December 2020

Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

1 reference

12 December 2020

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

1 reference

12 December 2020

Simvastatin with or without ezetimibe in familial hypercholesterolemia

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombol

1 reference

12 December 2020

The HDL proteome: a marker--and perhaps mediator--of coronary artery disease

1 reference

12 December 2020

Clinical evidence for use of acetyl salicylic acid in control of flushing related to nicotinic acid treatment

1 reference

12 December 2020

Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease

1 reference

12 December 2020

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

1 reference

12 December 2020

Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study

1 reference

12 December 2020

Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy

1 reference

12 December 2020

A Commentary on the implications of the ENHANCE (Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression) Trial: Should ezetimibe move to the "Back of the Line" as a therapy for dyslipidemia?

1 reference

12 December 2020

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial

1 reference

12 December 2020

Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.

1 reference

12 December 2020

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

1 reference

12 December 2020

Safety and compliance with once-daily niacin extended-release/lovastatin as initial therapy in the Impact of Medical Subspecialty on Patient Compliance to Treatment (IMPACT) study

1 reference

12 December 2020

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

1 reference

12 December 2020

The IDEAL cholesterol: lower is better

1 reference

12 December 2020

Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease.

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-alpha activation and high-density lipoprotein metabolism

1 reference

12 December 2020

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial

1 reference

12 December 2020

Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement

1 reference

12 December 2020

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

12 December 2020

Safety considerations with niacin therapy.

1 reference

12 December 2020

Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes

1 reference

12 December 2020

Clinical characterization and molecular mechanisms of statin myopathy

1 reference

12 December 2020

Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy

1 reference

12 December 2020

Inflammation in atherosclerosis

1 reference

12 December 2020

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

12 December 2020

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

12 December 2020

Drug therapy for hypertriglyceridemia: fibrates and omega-3 fatty acids

1 reference

12 December 2020

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

1 reference

12 December 2020

Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)

1 reference

12 December 2020

A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia

1 reference

12 December 2020

Omega-3 fatty acids for cardioprotection.

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Adherence with statin therapy in elderly patients with and without acute coronary syndromes

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

12 December 2020

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

12 December 2020

Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia

1 reference

12 December 2020

The Münster Heart Study (PROCAM). Results of follow-up at 8 years.

1 reference

12 December 2020

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

12 December 2020

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

1 reference

12 December 2020

High-dose statin therapy: benefits and safety in aggressive lipid lowering.

1 reference

12 December 2020

Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice

1 reference

12 December 2020

Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial

1 reference

12 December 2020

Molecular physiology of reverse cholesterol transport

1 reference

12 December 2020

Usefulness of omega-3 fatty acids and the prevention of coronary heart disease

1 reference

12 December 2020

The effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3

1 reference

12 December 2020

Cholesterol and lipids in the risk of coronary artery disease--the Framingham Heart Study

1 reference

12 December 2020

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

1 reference

12 December 2020

10.2165/10898610-000000000-00000

Identifiers

DOI

1 reference

PubMed ID

20614945

Dimensions Publication ID

22 August 2017

0 references

1 reference

PubMed ID

20614945